Featured Articles

• LT3001 DEMONSTRATES FUNCTIONAL IMPROVEMENTS IN PATIENTS WITH DISABLING ACUTE ISCHEMIC STROKE 08-02-2026

  TAIPEI, Feb. 7, 2026 /PRNewswire/ -- Lumosa Therapeutics (Lumosa; 6535.TWO) today announced positive results from two independent Phase 2 clinical trials with its novel stroke drug LT3001 (Odatroltide). LT3001 is a first-in-class dual-functional ther

  READ MORE
• Mum turns child's diagnosis into pledge to help 08-02-2026

  When mother to two healthy daughters Sami Glastonbury went for a routine scan during her third pregnancy, she felt confident and curious - but like it was just a formality. Instead, she watched the radiographer's expression change.[subscribe]

  READ MORE
• Medical workers 'robbed' child of chance at survival 06-02-2026

  Hospital staff and paramedics "robbed" a 15-year-old boy of his best chance at survival by failing to intervene earlier after he suffered an allergic reaction, his grieving parents say. Melbourne teen Max McKenzie died in August 2021 aft

  READ MORE
• Major study debunks cholesterol drug side-effect fears 06-02-2026

  Millions of Australians using drugs to combat bad cholesterol can rest easier after scientists dispelled common concerns over side effects. Despite being highly effective at reducing low-density lipoprotein cholesterol, statins have long been blam

  READ MORE
• Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial 05-02-2026

  Landmark Australian study opens new possibilities for children with aggressive brain tumors and signals opportunity for Canada and USA. CALGARY, AB and BRISBANE, Australia , Feb. 5, 2026 /PRNewswire/ -- Providence Therapeutics, a Canadian clinical

  READ MORE
• Number of young Australians with dementia to soar 05-02-2026

  More than a million Australians are projected to develop dementia in the next four decades, with the number of early onset cases expected to soar, advocates say. Data released on Thursday reveals people living with young onset dementia, when the s

  READ MORE
• The silent addiction unfolding in Australian classrooms 05-02-2026

  Nicotine addiction is taking hold of a new, vulnerable generation of Australians as research shows the crisis is unfolding quietly and in plain sight. Twelve per cent of teenagers nationwide use at least one nicotine product, while 15 per cent are

  READ MORE
• 'Too long': green light for more GPs to tackle ADHD 03-02-2026

  Australians will soon find it much smoother to be diagnosed and treated for attention deficit hyperactivity disorder. Victoria has joined a growing list of states to give the green light for general practitioners to tackle ADHD, which is estimated

  READ MORE
• Thriving Kids aims to 'mainstream' disability support 03-02-2026

  Families, schools and early learning providers will bear greater responsibility for caring for children with developmental delays and mild autism in a major shake-up of Australia's disability support system. The $4 billion Thriving Kids progra

  READ MORE
• 'Blind spot': alarm sounded on weight-loss medications 03-02-2026

  While weight-loss medications are often hailed as wonder drugs for improving the lives of people battling obesity, dietitians are increasingly concerned about the lack of research into long-term nutritional health impacts. At least half a million

  READ MORE